Market Overview:
With increased awareness about skin health, Dermatology Diagnostic Device Market Share is anticipated to register considerable growth across the world. Skin is the largest organ in the human body and as a result is responsible for a significant portion of problems in human health. More often than not problems apparent on the skin are the reflection of a greater underlying problem elsewhere in the body. Moreover, as governments across several regions are working to expand healthcare facilities to all, greater number of people with skin diseases like rosacea, psoriasis, eczema, hives etc. have come to be diagnosed, a factor that has been a strong driving force for dermatology diagnostic device market.
Advancement in dermatology diagnostic technologies has enabled practitioners to diagnose and treat skin diseases more effectively. Latest developments in skincare technology is helping to solve some of the biggest challenges in the dermatology related healthcare industry. For instance, recently in a research led by Royal Free London NHS Trust, AI has been used in dermatology. DERM as the AI platform is called was successful in correctly identifying malignant lesions with greater specificity than clinical experts. DERM, which has acquired the CE mark is a medical device, that can aid in detecting 11 common skin lesion types, including melanoma.
Early diagnosis of melanoma is important as it is one of the forms of cancer that has registered an augmented incidence in the recent years. Melanoma is the cause for majority of skin cancer deaths. The factor that has added impetus to dermatology diagnostic device market size is the fact that patients diagnosed with stage I melanoma have a 95% chance of survival while those diagnosed at stage IV have an 8%-25% chance.
Competitive Scenario:
• Valeant Pharmaceuticals
• Cutera
• Alma Laser
• Dino-Lite Europe/IDCP B.V.
• Galderma S.A.
• Cynosure
• Lumenis
• Ltd. Genentech
• Michelson Diagnostics Ltd
Segmentation:
• Dermatology diagnostic device market is segmented by diagnostic devices, application of devices and end users.
• On the basis of diagnostic device, the dermatology diagnostic device market is divided into imaging devices, dermatoscopes and microscopes.
• Application-wise, dermatology diagnostic device market is subdivided by the application of devices such as skin cancer, lesion and others.
• According to end users, dermatology diagnostic device market is classified into hospitals, institutions, research labs and centers and others.
Regional Analysis:
Disposable income, increased health awareness and growing incidence of number of skin case diseases mainly due to deteriorating environmental conditions will add a considerable impetus to the expansion of dermatology diagnostic device market. Region-wise, prevailing trends in the market can be evaluated on the basis of four geographies including the Americas, Europe, Asia Pacific and Middle East and Africa.
Awareness about skin health and the benefits of early detection of dermatological problems has created potent scope for the growth of dermatology diagnostic device market. A growing geriatric population across the various regions has led to the occurrence of greater number of skin related disorders that has prompted healthcare providers to focus on offering expanded dermatology solutions. With better access to superior healthcare services, such trends in the dermatology diagnostic device market are expected to be witnessed in the developed nations of North America and Europe.
Rising middle class with increased income, greater expenditure on healthcare and significant government initiatives to increase access to efficient healthcare services in Asia Pacific are factor that are anticipated to drive the growth of dermatology diagnostic device market in the region.